Harel Insurance Investments & Financial Services’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,145
Closed -$3K 765
2022
Q3
$3K Sell
1,145
-76
-6% -$323 ﹤0.01% 684
2022
Q2
$6K Sell
1,221
-127
-9% -$665 ﹤0.01% 685
2022
Q1
$10K Sell
1,348
-258
-16% -$2.13K ﹤0.01% 661
2021
Q4
$30K Buy
+1,606
New +$34.7K ﹤0.01% 653

Other funds holding CELL

Harel Insurance Investments & Financial Services's CELL Position: Q4 2022 in Review

Harel Insurance Investments & Financial Services sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 1,145 shares — an estimated $3K sold.

Harel Insurance Investments & Financial Services first reported a position in CELL in Q4 2021 and held it in 4 quarters. The position peaked at $30K in Q4 2021. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.

  • Harel Insurance Investments & Financial Services reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,145 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Harel Insurance Investments & Financial Services first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Harel Insurance Investments & Financial Services's PhenomeX Inc. Common Stock position peaked at $30K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2022, filed 26 Jan 2023.